Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 386

1.

Alpha-linolenic acid based nano-suspension protect against lipopolysaccharides induced mastitis by inhibiting NFκBp65, HIF-1α, and mitochondria-mediated apoptotic pathway in albino Wistar rats.

Yadav RK, Tripathi CB, Saraf SA, Ansari MN, Saeedan AS, Aldosary S, Rajinikanth PS, Kaithwas G.

Toxicol Appl Pharmacol. 2019 Jun 14:114628. doi: 10.1016/j.taap.2019.114628. [Epub ahead of print]

PMID:
31207257
2.

Laparoscopic Sleeve Gastrectomy in Sickle Cell Disease: a Case Series.

Han J, Gowhari M, Gordeuk VR, Saraf SL.

Obes Surg. 2019 Jun 10. doi: 10.1007/s11695-019-03983-5. [Epub ahead of print]

PMID:
31183783
3.

PHD-2 activation: a novel strategy to control HIF-1α and mitochondrial stress to modulate mammary gland pathophysiology in ER+ subtype.

Devi U, Singh M, Roy S, Tripathi AC, Gupta PS, Saraf SK, Ansari MN, Saeedan AS, Kaithwas G.

Naunyn Schmiedebergs Arch Pharmacol. 2019 Jun 1. doi: 10.1007/s00210-019-01658-7. [Epub ahead of print]

PMID:
31154466
4.

Fixation of Posterior Tibial Plateau Fracture with Additional Posterior Plating Improves Early Rehabilitation and Patient Satisfaction.

Sinha S, Singh M, Saraf SK, Rastogi A, Rai AK, Singh TB.

Indian J Orthop. 2019 May-Jun;53(3):472-478. doi: 10.4103/ortho.IJOrtho_295_18.

5.

Type 2 diabetes in adults with sickle cell disease: can we dive deeper? Response to Skinner et al.

Zhou J, Han J, Nutescu EA, Galanter WL, Walton SM, Gordeuk VR, Saraf SL, Calip GS.

Br J Haematol. 2019 May 8. doi: 10.1111/bjh.15949. [Epub ahead of print] No abstract available.

PMID:
31066029
6.

Systematic optimization of cationic surface engineered mucoadhesive vesicles employing Design of Experiment (DoE): A preclinical investigation.

Verma A, Sharma G, Jain A, Tiwari A, Saraf S, Panda PK, Katare OP, Jain SK.

Int J Biol Macromol. 2019 Jul 15;133:1142-1155. doi: 10.1016/j.ijbiomac.2019.04.118. Epub 2019 Apr 17.

PMID:
31004631
7.

Familial retinal arteriolar tortuosity and quantification of vascular tortuosity using swept-source optical coherence tomography angiography.

Saraf SS, Tyring AJ, Chen CL, Le TP, Kalina RE, Wang RK, Chao JR.

Am J Ophthalmol Case Rep. 2019 Mar 7;14:74-78. doi: 10.1016/j.ajoc.2019.03.001. eCollection 2019 Jun.

8.

Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and H.

Gubens MA, Sequist LV, Stevenson JP, Powell SF, Villaruz LC, Gadgeel SM, Langer CJ, Patnaik A, Borghaei H, Jalal SI, Fiore J, Saraf S, Raftopoulos H, Gandhi L.

Lung Cancer. 2019 Apr;130:59-66. doi: 10.1016/j.lungcan.2018.12.015. Epub 2018 Dec 17.

PMID:
30885353
9.

Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma.

Jangdey MS, Kaur CD, Saraf S.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):904-916. doi: 10.1080/21691401.2019.1578784.

PMID:
30856018
10.

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer.

Mehnert JM, Varga A, Brose MS, Aggarwal RR, Lin CC, Prawira A, de Braud F, Tamura K, Doi T, Piha-Paul SA, Gilbert J, Saraf S, Thanigaimani P, Cheng JD, Keam B.

BMC Cancer. 2019 Mar 4;19(1):196. doi: 10.1186/s12885-019-5380-3.

11.

The morbidity and mortality of end stage renal disease in sickle cell disease.

Viner M, Zhou J, Allison D, Han J, Molokie RE, Jain S, Gowhari M, Gordeuk VR, Calip G, Saraf SL.

Am J Hematol. 2019 May;94(5):E138-E141. doi: 10.1002/ajh.25439. Epub 2019 Mar 1. No abstract available.

PMID:
30773675
12.

Biotin anchored nanostructured lipid carriers for targeted delivery of doxorubicin in management of mammary gland carcinoma through regulation of apoptotic modulator.

Tripathi CB, Parashar P, Arya M, Singh M, Kanoujia J, Kaithwas G, Saraf SA.

J Liposome Res. 2019 Feb 10:1-16. doi: 10.1080/08982104.2019.1579839. [Epub ahead of print]

PMID:
30741049
13.

Long-Term Durability of Transcatheter Aortic Valve Prostheses.

Blackman DJ, Saraf S, MacCarthy PA, Myat A, Anderson SG, Malkin CJ, Cunnington MS, Somers K, Brennan P, Manoharan G, Parker J, Aldalati O, Brecker SJ, Dowling C, Hoole SP, Dorman S, Mullen M, Kennon S, Jerrum M, Chandrala P, Roberts DH, Tay J, Doshi SN, Ludman PF, Fairbairn TA, Crowe J, Levy RD, Banning AP, Ruparelia N, Spence MS, Hildick-Smith D.

J Am Coll Cardiol. 2019 Feb 12;73(5):537-545. doi: 10.1016/j.jacc.2018.10.078.

PMID:
30732706
14.

Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.

Zhou J, Han J, Nutescu EA, Galanter WL, Walton SM, Gordeuk VR, Saraf SL, Calip GS.

Br J Haematol. 2019 Apr;185(1):116-127. doi: 10.1111/bjh.15773. Epub 2019 Feb 3.

PMID:
30714090
15.

In vitro and in silico molecular interaction of multiphase nanoparticles containing inositol hexaphosphate and jacalin: Therapeutic potential against colon cancer cells (HCT-15).

Arya M, Mishra N, Singh P, Tripathi CB, Parashar P, Singh M, Gupta KP, Saraf SA.

J Cell Physiol. 2019 Jan 29. doi: 10.1002/jcp.28200. [Epub ahead of print]

PMID:
30697733
16.

Manipulated: graphic health warnings on smokeless tobacco in rural India.

Iacobelli M, Saraf S, Welding K, Clegg Smith K, Cohen JE.

Tob Control. 2019 Jan 29. pii: tobaccocontrol-2018-054715. doi: 10.1136/tobaccocontrol-2018-054715. [Epub ahead of print] No abstract available.

17.

Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer's Disease.

Dubey SK, Ram MS, Krishna KV, Saha RN, Singhvi G, Agrawal M, Ajazuddin, Saraf S, Saraf S, Alexander A.

Cell Mol Neurobiol. 2019 Mar;39(2):181-209. doi: 10.1007/s10571-019-00653-z. Epub 2019 Jan 23. Review.

PMID:
30671696
18.

A synergistic approach for management of lung carcinoma through folic acid functionalized co-therapy of capsaicin and gefitinib nanoparticles: Enhanced apoptosis and metalloproteinase-9 down-regulation.

Parashar P, Tripathi CB, Arya M, Kanoujia J, Singh M, Yadav A, Kaithwas G, Saraf SA.

Phytomedicine. 2019 Feb;53:107-123. doi: 10.1016/j.phymed.2018.09.013. Epub 2018 Sep 4.

PMID:
30668390
19.

"Maximum tolerated dose" vs "fixed low-dose" hydroxyurea for treatment of adults with sickle cell anemia.

Akingbola TS, Tayo BO, Ezekekwu CA, Sonubi O, Zhang X, Saraf SL, Molokie R, Hsu LL, Han J, Cooper RS, Gordeuk VR.

Am J Hematol. 2019 Apr;94(4):E112-E115. doi: 10.1002/ajh.25412. Epub 2019 Feb 6. No abstract available.

PMID:
30663794
20.

Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H3 Receptor Inverse Agonist with Robust Wake-Promoting Activity.

Nirogi R, Shinde A, Mohammed AR, Badange RK, Reballi V, Bandyala TR, Saraf SK, Bojja K, Manchineella S, Achanta PK, Kandukuri KK, Subramanian R, Benade V, Palacharla RC, Jayarajan P, Pandey S, Jasti V.

J Med Chem. 2019 Feb 14;62(3):1203-1217. doi: 10.1021/acs.jmedchem.8b01280. Epub 2019 Jan 25.

PMID:
30629436
21.

Vision Restoration in Outer Retinal Degenerations: Current Approaches and Future Directions.

Saraf SS, Olmos de Koo LC.

Int Ophthalmol Clin. 2019 Winter;59(1):59-69. doi: 10.1097/IIO.0000000000000257. No abstract available.

PMID:
30585918
22.

Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation.

Yang JC, Gadgeel SM, Sequist LV, Wu CL, Papadimitrakopoulou VA, Su WC, Fiore J, Saraf S, Raftopoulos H, Patnaik A.

J Thorac Oncol. 2019 Mar;14(3):553-559. doi: 10.1016/j.jtho.2018.11.028. Epub 2018 Dec 4.

PMID:
30529597
23.

Dextrose modified bilosomes for peroral delivery: improved therapeutic potential and stability of silymarin in diethylnitrosamine-induced hepatic carcinoma in rats.

Parashar P, Rana P, Dwivedi M, Saraf SA.

J Liposome Res. 2018 Dec 2:1-13. doi: 10.1080/08982104.2018.1551408. [Epub ahead of print]

PMID:
30501440
24.

Pectin-encrusted gold nanocomposites containing phytic acid and jacalin: 1,2-dimethylhydrazine-induced colon carcinogenesis in Wistar rats, PI3K/Akt, COX-2, and serum metabolomics as potential targets.

Arya M, Singh P, Tripathi CB, Parashar P, Singh M, Kanoujia J, Guleria A, Kaithwas G, Gupta KP, Saraf SA.

Drug Deliv Transl Res. 2019 Feb;9(1):53-65. doi: 10.1007/s13346-018-00605-y.

PMID:
30484258
25.

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.

Gadgeel SM, Stevenson JP, Langer CJ, Gandhi L, Borghaei H, Patnaik A, Villaruz LC, Gubens M, Hauke R, Yang JC, Sequist LV, Bachman R, Saraf S, Raftopoulos H, Papadimitrakopoulou V.

Lung Cancer. 2018 Nov;125:273-281. doi: 10.1016/j.lungcan.2018.08.019. Epub 2018 Aug 25.

PMID:
30429032
26.

Anterior cervical incision-sparing thyroidectomy: Comparing retroauricular and transoral approaches.

Russell JO, Razavi CR, Al Khadem MG, Lopez M, Saraf S, Prescott JD, Starmer HM, Richmon JD, Tufano RP.

Laryngoscope Investig Otolaryngol. 2018 Sep 24;3(5):409-414. doi: 10.1002/lio2.200. eCollection 2018 Oct.

27.

Initial experience of a large, self-expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters' registry.

Dowling C, Firoozi S, Doyle N, Blackman DJ, Malkin CJ, Cunnington MS, Saraf S, Buch MH, Levy R, Chowdhary S, Spence MS, Manoharan G, Owens CG, Brennan PF, Roberts D, More R, Wiper A, Abdelaziz HK, Mylotte D, Neylon A, Martin N, Mercanti F, Dorman S, Panoulas V, Dalby M, Kashyap MN, Kabir T, Kovac J, Kontoprias K, Malik IS, Ghada MW, Sen S, Ruparelia N, Demir OM, Frame A, Uren NG, Anderson R, Rajathurai T, Tapp L, Deegan L, Grech E, Hall I, Neville M, Rampat R, Hildick-Smith D, Mullen M, Kennon S, Chandrala P, Doshi S, Brecker SJ.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):751-757. doi: 10.1002/ccd.27934. Epub 2018 Nov 5.

PMID:
30394657
28.

Biomedical applications of microemulsion through dermal and transdermal route.

Shukla T, Upmanyu N, Agrawal M, Saraf S, Saraf S, Alexander A.

Biomed Pharmacother. 2018 Dec;108:1477-1494. doi: 10.1016/j.biopha.2018.10.021. Epub 2018 Oct 8. Review.

29.

Novel targeting approaches and signaling pathways of colorectal cancer: An insight.

Tiwari A, Saraf S, Verma A, Panda PK, Jain SK.

World J Gastroenterol. 2018 Oct 21;24(39):4428-4435. doi: 10.3748/wjg.v24.i39.4428.

30.

Use of metformin in patients with sickle cell disease.

Han J, Saraf SL, Molokie RE, Gordeuk VR.

Am J Hematol. 2019 Jan;94(1):E13-E15. doi: 10.1002/ajh.25313. Epub 2018 Nov 9. No abstract available.

PMID:
30328140
31.

Nose-to-brain drug delivery approach: A key to easily accessing the brain for the treatment of Alzheimer's disease.

Alexander A, Saraf S.

Neural Regen Res. 2018 Dec;13(12):2102-2104. doi: 10.4103/1673-5374.241458. No abstract available.

32.

Biotinylated naringenin intensified anticancer effect of gefitinib in urethane-induced lung cancer in rats: favourable modulation of apoptotic regulators and serum metabolomics.

Parashar P, Tripathi CB, Arya M, Kanoujia J, Singh M, Yadav A, Kumar A, Guleria A, Saraf SA.

Artif Cells Nanomed Biotechnol. 2018;46(sup3):S598-S610. doi: 10.1080/21691401.2018.1505738. Epub 2018 Oct 16.

PMID:
30322263
33.

Ultra-wide optical coherence tomography angiography in diabetic retinopathy.

Zhang Q, Rezaei KA, Saraf SS, Chu Z, Wang F, Wang RK.

Quant Imaging Med Surg. 2018 Sep;8(8):743-753. doi: 10.21037/qims.2018.09.02.

34.

High inpatient dose of opioid at discharge compared to home dose predicts readmission risk in sickle cell disease.

Han J, Saraf SL, Gowhari M, Jain S, Molokie RE, Gordeuk VR.

Am J Hematol. 2019 Jan;94(1):E5-E7. doi: 10.1002/ajh.25311. Epub 2018 Oct 31. No abstract available.

PMID:
30299555
35.

Stem Cell-Based Therapies: A New Ray of Hope for Diabetic Patients.

Khan J, Alexander A, Agrawal M, Ajazuddin, Dubey SK, Siddique S, Saraf S, Saraf S.

Curr Stem Cell Res Ther. 2019;14(2):146-151. doi: 10.2174/1574888X13666181002154110.

PMID:
30280677
36.

Recent Biomedical Applications on Stem Cell Therapy: A Brief Overview.

Agrawal M, Alexander A, Khan J, Giri TK, Siddique S, Dubey SK, Ajazuddin, Patel RJ, Gupta U, Saraf S, Saraf S.

Curr Stem Cell Res Ther. 2019;14(2):127-136. doi: 10.2174/1574888X13666181002161700.

PMID:
30280676
37.

Trans-catheter aortic valve implantation without contrast using the Lotus mechanically-expanded heart valve.

Ali N, Saraf S, Schlosshan D, Cunnington M, Malkin CJ, Blackman DJ.

J Cardiol Cases. 2018 Jul 17;18(4):141-144. doi: 10.1016/j.jccase.2018.06.007. eCollection 2018 Oct.

38.

A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.

Parashar P, Tripathi CB, Arya M, Kanoujia J, Singh M, Yadav A, Saraf SA.

Drug Deliv Transl Res. 2019 Feb;9(1):37-52. doi: 10.1007/s13346-018-0575-8.

PMID:
30178279
39.

HMOX1 and acute kidney injury in sickle cell anemia.

Saraf SL, Viner M, Rischall A, Raslan R, Shah BN, Zhang X, Han J, Gowhari M, Jain S, Molokie RE, Machado RF, Lash JP, Gordeuk VR.

Blood. 2018 Oct 11;132(15):1621-1625. doi: 10.1182/blood-2018-05-853929. Epub 2018 Aug 23. No abstract available.

PMID:
30139825
40.

24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer.

Borghaei H, Langer CJ, Gadgeel S, Papadimitrakopoulou VA, Patnaik A, Powell SF, Gentzler RD, Martins RG, Stevenson JP, Jalal SI, Panwalkar A, Yang JC, Gubens M, Sequist LV, Awad MM, Fiore J, Saraf S, Keller SM, Gandhi L.

J Thorac Oncol. 2019 Jan;14(1):124-129. doi: 10.1016/j.jtho.2018.08.004. Epub 2018 Aug 21.

PMID:
30138764
41.

Hemolysis and hemolysis-related complications in females vs. males with sickle cell disease.

Raslan R, Shah BN, Zhang X, Kanias T, Han J, Machado RF, Gladwin MT, Gordeuk VR, Saraf SL.

Am J Hematol. 2018 Nov;93(11):E376-E380. doi: 10.1002/ajh.25258. Epub 2018 Oct 17. No abstract available.

PMID:
30117177
42.

Understanding the prospective of nano-formulations towards the treatment of psoriasis.

Pradhan M, Alexander A, Singh MR, Singh D, Saraf S, Saraf S, Ajazuddin.

Biomed Pharmacother. 2018 Nov;107:447-463. doi: 10.1016/j.biopha.2018.07.156. Epub 2018 Aug 10. Review.

PMID:
30103117
43.

Importance of combined approach of investigations for detection of asymptomatic Hashimoto Thyroiditis in early stage.

Saraf SR, Gadgil NM, Yadav S, Kalgutkar AD.

J Lab Physicians. 2018 Jul-Sep;10(3):294-298. doi: 10.4103/JLP.JLP_72_17.

44.

Differentially Expressed MicroRNAs Link Cellular Physiology to Phenotypic Changes in Rice Under Stress Conditions.

Grewal RK, Saraf S, Deb A, Kundu S.

Plant Cell Physiol. 2018 Oct 1;59(10):2143-2154. doi: 10.1093/pcp/pcy136.

PMID:
30010993
45.

Perspectives of Lipid-Based Drug Carrier Systems for Transdermal Delivery.

Pradhan M, Srivastava S, Singh D, Saraf S, Saraf S, Singh MR.

Crit Rev Ther Drug Carrier Syst. 2018;35(4):331-367. doi: 10.1615/CritRevTherDrugCarrierSyst.2018020856. Review.

PMID:
29972681
46.

Pattern of dental caries in 3-6-year-old children using decayed, missing, filled surface index and hierarchical caries pattern system: A descriptive study.

Chandan GD, Saraf S, Sangavi N, Khatri A.

J Indian Soc Pedod Prev Dent. 2018 Apr-Jun;36(2):108-112. doi: 10.4103/JISPPD.JISPPD_1183_17.

47.

Amalgamation of Stem Cells with Nanotechnology: A Unique Therapeutic Approach.

Alexander A, Saraf S, Saraf S, Agrawal M, Patel RJ, Agrawal P, Khan J, Ajazuddin.

Curr Stem Cell Res Ther. 2019;14(2):83-92. doi: 10.2174/1574888X13666180703143219.

PMID:
29968543
48.

Exploring the role of polymeric conjugates toward anti-cancer drug delivery: Current trends and future projections.

Khan J, Alexander A, Ajazuddin, Saraf S, Saraf S.

Int J Pharm. 2018 Sep 5;548(1):500-514. doi: 10.1016/j.ijpharm.2018.06.060. Epub 2018 Jun 28. Review.

PMID:
29964172
49.

Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.

Guilcher GMT, Truong TH, Saraf SL, Joseph JJ, Rondelli D, Hsieh MM.

Semin Hematol. 2018 Apr;55(2):87-93. doi: 10.1053/j.seminhematol.2018.04.011. Epub 2018 Apr 25. Review.

50.

Microbial bio-fuels: a solution to carbon emissions and energy crisis.

Kumar A, Kaushal S, Saraf SA, Singh JS.

Front Biosci (Landmark Ed). 2018 Jun 1;23:1789-1802. Review.

PMID:
29772529

Supplemental Content

Support Center